Denk Pharma GmbH & Co. KG


Germany-based manufacturer of pharmaceutical products and dietary supplements with a reported operational history of more than 75 years and product distribution in over 80 markets. The company operates manufacturing sites in Germany, publishes educational and drug-safety materials for patients and healthcare professionals, and emphasizes product quality under a national quality program. The corporate website publishes a detailed accessibility statement (dated 29 September 2026) describing adherence goals to WCAG 2.1 AA and implementation of multiple assistive-technology measures.

Industries

Health Care
Pharmaceutical
Pharmaceutical Manufacturing

Nr. of Employees

medium (51-250)

Denk Pharma GmbH & Co. KG


Products

Imatinib (pharmaceutical)

Oral oncology medicine indicated for certain hematologic cancers (example listing on site).

Acyclovir (pharmaceutical)

Antiviral medicine for treatment of viral infections (site product listing).

Ibuprofen (pharmaceutical)

Analgesic and antipyretic product for short-term symptomatic treatment of mild to moderate pain and fever.


Services

Business-to-business supply channels for pharmaceutical ingredients and nutritional/dietary products with online B2B contact points.

Expertise Areas

  • Pharmaceutical manufacturing
  • Dietary supplement manufacturing
  • Primary packaging development and selection
  • Quality management and regulatory compliance
  • Show More (4)

Key Technologies

  • Good Manufacturing Practice (GMP)
  • Multi-layer laminate packaging (PE/Aluminium/Surlyn; foil laminates)
  • Plastic and aluminium tube packaging
  • Glass ampoules and vials
  • Show More (7)

News & Updates

News item describing a strategic cooperation between the company and the Syndicate of Iraqi Pharmacists.

News item describing a partnership with the International Pharmaceutical Federation (FIP).

Company reports more than 75 years of operation.

Products reportedly distributed in over 80 markets worldwide.

Published a detailed website accessibility statement describing WCAG 2.1 AA goals and implemented assistive-technology measures.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.